Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.85% |
| Sep 30, 2025 | 45.48% |
| Jun 30, 2025 | 48.28% |
| Mar 31, 2025 | 16.40% |
| Dec 31, 2024 | 31.61% |
| Sep 30, 2024 | 16.23% |
| Jun 30, 2024 | -17.42% |
| Mar 31, 2024 | -16.81% |
| Dec 31, 2023 | -21.22% |
| Sep 30, 2023 | -16.11% |
| Jun 30, 2023 | -20.41% |
| Mar 31, 2023 | -22.52% |
| Dec 31, 2020 | -2.45% |
| Sep 30, 2020 | -28.19% |
| Jun 30, 2020 | -33.88% |
| Mar 31, 2020 | -26.41% |
| Dec 31, 2019 | -18.86% |
| Sep 30, 2019 | -20.71% |
| Jun 30, 2019 | 2.08% |
| Mar 31, 2019 | 78.88% |
| Sep 30, 2018 | 132.31% |
| Jun 30, 2018 | 23.25% |
| Mar 31, 2018 | -5.22% |
| Dec 31, 2017 | -68.28% |